These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29799646)

  • 1. Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis.
    Elias PM
    Exp Dermatol; 2018 Aug; 27(8):847-851. PubMed ID: 29799646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier repair therapy in atopic dermatitis: an overview.
    Hon KL; Leung AK; Barankin B
    Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
    Kubo A; Nagao K; Amagai M
    J Clin Invest; 2012 Feb; 122(2):440-7. PubMed ID: 22293182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients.
    van Smeden J; Bouwstra JA
    Curr Probl Dermatol; 2016; 49():8-26. PubMed ID: 26844894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
    Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
    J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the epidermal barrier in atopic dermatitis.
    Proksch E; Fölster-Holst R; Bräutigam M; Sepehrmanesh M; Pfeiffer S; Jensen JM
    J Dtsch Dermatol Ges; 2009 Oct; 7(10):899-910. PubMed ID: 19682176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis.
    Wolf R; Wolf D
    Clin Dermatol; 2012; 30(3):329-34. PubMed ID: 22507048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eczema and ceramides: an update.
    Jungersted JM; Agner T
    Contact Dermatitis; 2013 Aug; 69(2):65-71. PubMed ID: 23869725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.
    Elias PM; Wakefield JS
    J Allergy Clin Immunol; 2014 Oct; 134(4):781-791.e1. PubMed ID: 25131691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstructed human epidermis for in vitro studies on atopic dermatitis: A review.
    Huet F; Severino-Freire M; Chéret J; Gouin O; Praneuf J; Pierre O; Misery L; Le Gall-Ianotto C
    J Dermatol Sci; 2018 Mar; 89(3):213-218. PubMed ID: 29248403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutations within the filaggrin gene and atopic dermatitis.
    Kawasaki H; Kubo A; Sasaki T; Amagai M
    Curr Probl Dermatol; 2011; 41():35-46. PubMed ID: 21576945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
    Elias PM; Wakefield JS
    Clin Rev Allergy Immunol; 2011 Dec; 41(3):282-95. PubMed ID: 21174234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.
    Elias PM; Wakefield JS; Man MQ
    Skin Pharmacol Physiol; 2019; 32(1):1-7. PubMed ID: 30336483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.
    Thyssen JP; Kezic S
    J Allergy Clin Immunol; 2014 Oct; 134(4):792-9. PubMed ID: 25065719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
    Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
    Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing emollient therapy for skin barrier repair in atopic dermatitis.
    Elias PM
    Ann Allergy Asthma Immunol; 2022 May; 128(5):505-511. PubMed ID: 35065300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling.
    Angelova-Fischer I; Mannheimer AC; Hinder A; Ruether A; Franke A; Neubert RH; Fischer TW; Zillikens D
    Exp Dermatol; 2011 Apr; 20(4):351-6. PubMed ID: 21410766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin barrier in atopic dermatitis.
    Kezic S; Novak N; Jakasa I; Jungersted JM; Simon M; Brandner JM; Middelkamp-Hup MA; Weidinger S
    Front Biosci (Landmark Ed); 2014 Jan; 19(3):542-56. PubMed ID: 24389202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filaggrin mutations and atopy: consequences for future therapeutics.
    Heimall J; Spergel JM
    Expert Rev Clin Immunol; 2012 Feb; 8(2):189-97. PubMed ID: 22288457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron diffraction study of lipids in non-lesional stratum corneum of atopic eczema patients.
    Janssens M; Mulder AA; van Smeden J; Pilgram GS; Wolterbeek R; Lavrijsen AP; Koning RI; Koster AJ; Bouwstra JA
    Biochim Biophys Acta; 2013 Aug; 1828(8):1814-21. PubMed ID: 23583924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.